NextCure, Inc.NXTCNASDAQ
Loading
Year-over-year book value per share growth
| Period | Value |
|---|---|
| Q4 2025 | 12.81% |
| Q3 2025 | -33.69% |
| Q2 2025 | -44.32% |
| Q1 2025 | -14.69% |
| Q4 2024 | -13.48% |
| Q3 2024 | -11.54% |
| Q2 2024 | -13.95% |
| Q1 2024 | -13.41% |
| Q4 2023 | -9.74% |
| Q3 2023 | -8.69% |
| Q2 2023 | -10.40% |
| Q1 2023 | -7.95% |
| Q4 2022 | -7.80% |
| Q3 2022 | -8.42% |
| Q2 2022 | -7.48% |
| Q1 2022 | -8.56% |
| Q4 2021 | -6.07% |
| Q3 2021 | -5.85% |
| Q2 2021 | -5.62% |
| Q1 2021 | -5.06% |
| Q4 2020 | -4.50% |
| Q3 2020 | -4.63% |
| Q2 2020 | -3.01% |
| Q1 2020 | 3.17% |
| Q4 2019 | 55.62% |
| Q3 2019 | -43.22% |
| Q2 2019 | 670.15% |
| Q1 2019 | -495.49% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |